PDB18 THE COST-EFFECTIVENESS OF PIOGLITAZONE COMPARED WITH ROSIGLITAZONE-AN ECONOMIC EVALUATION PROJECTING RESULTS FROM A CLINICAL STUDY INTOTHE FUTURE USING AVALID AND RELIABLE ECONOMIC MODEL FROM ATHIRD PARTY PAYER PERSPECTIVE IN THE USA
Abstract
Authors
M Minshall M St. Charles B Pandya RW Baran